TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst et al.PubMed ↗Publisher ↗

No numbers read from the abstract.